Acta Neuropathologica

, Volume 128, Issue 3, pp 449–452 | Cite as

Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants

  • Sonja Hutter
  • Rosario M. Piro
  • David E. Reuss
  • Volker Hovestadt
  • Felix Sahm
  • Said Farschtschi
  • Hildegard Kehrer-Sawatzki
  • Stephan Wolf
  • Peter Lichter
  • Andreas von Deimling
  • Martin U. Schuhmann
  • Stefan M. Pfister
  • David T. W. Jones
  • Victor F. Mautner
Correspondence

Supplementary material

401_2014_1311_MOESM1_ESM.docx (426 kb)
Supplementary material 1 (DOCX 427 kb)
401_2014_1311_MOESM2_ESM.xlsx (14 kb)
Supplementary material 2 (XLSX 13 kb)

References

  1. 1.
    Alexandrov LB, Nik-Zainal S, Wedge DC et al (2013) Signatures of mutational processes in human cancer. Nature 500(7463):415–421. doi:10.1038/nature12477 PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74(4):358–366. doi:10.1111/j.1399-0004.2008.01060.x PubMedCrossRefGoogle Scholar
  3. 3.
    Frattini V, Trifonov V, Chan JM et al (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet 45(10):1141–1149. doi:10.1038/ng.2734 PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Hadfield KD, Newman WG, Bowers NL et al (2008) Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet 45(6):332–339. doi:10.1136/jmg.2007.056499 PubMedCrossRefGoogle Scholar
  5. 5.
    Jacoby LB, Jones D, Davis K et al (1997) Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61(6):1293–1302. doi:10.1086/301633 PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Kaufman DL, Heinrich BS, Willett C et al (2003) Somatic instability of the NF2 gene in schwannomatosis. Arch Neurol 60(9):1317–1320. doi:10.1001/archneur.60.9.1317 PubMedCrossRefGoogle Scholar
  7. 7.
    MacCollin M, Chiocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64(11):1838–1845. doi:10.1212/01.WNL.0000163982.78900.AD PubMedCrossRefGoogle Scholar
  8. 8.
    MacCollin M, Willett C, Heinrich B et al (2003) Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 60(12):1968–1974PubMedCrossRefGoogle Scholar
  9. 9.
    Piotrowski A, Xie J, Liu YF et al (2013) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nature Genet 46(2):182–187. doi:10.1038/ng.2855 PubMedCrossRefGoogle Scholar
  10. 10.
    Rousseau G, Noguchi T, Bourdon V, Sobol H, Olschwang S (2011) SMARCB1/INI1 germline mutations contribute to 10 % of sporadic schwannomatosis. BMC Neurol 11(1):9. doi:10.1186/1471-2377-11-9 PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29(2):227–231. doi:10.1002/humu.20679 PubMedCrossRefGoogle Scholar
  12. 12.
    Smith MJ, Wallace AJ, Bowers NL et al (2012) Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics 13(2):141–145. doi:10.1007/s10048-012-0319-8 PubMedCrossRefGoogle Scholar
  13. 13.
    Zhang K, Lin JW, Wang J et al (2014) A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis. Genet Med Off J Am Coll Med Genet. doi:10.1038/gim.2014.39 Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Sonja Hutter
    • 1
  • Rosario M. Piro
    • 2
    • 3
  • David E. Reuss
    • 4
  • Volker Hovestadt
    • 2
  • Felix Sahm
    • 4
  • Said Farschtschi
    • 5
  • Hildegard Kehrer-Sawatzki
    • 6
  • Stephan Wolf
    • 7
  • Peter Lichter
    • 2
    • 3
    • 8
  • Andreas von Deimling
    • 4
  • Martin U. Schuhmann
    • 9
  • Stefan M. Pfister
    • 1
    • 10
  • David T. W. Jones
    • 1
  • Victor F. Mautner
    • 5
  1. 1.Division of Pediatric NeurooncologyGerman Cancer Research Center (DKFZ)HeidelbergGermany
  2. 2.Division of Molecular GeneticsGerman Cancer Research Center (DKFZ)HeidelbergGermany
  3. 3.German Cancer Consortium (DKTK)HeidelbergGermany
  4. 4.Department of NeuropathologyHeidelberg University HospitalHeidelbergGermany
  5. 5.Department of NeurologyUniversity Hospital Hamburg-EppendorfHamburgGermany
  6. 6.Institute of Human GeneticsUniversity of UlmUlmGermany
  7. 7.Genomics and Proteomics Core FacilityGerman Cancer Research Center (DKFZ)HeidelbergGermany
  8. 8.Heidelberg Center for Personalized Oncology (DKFZ-HIPO)HeidelbergGermany
  9. 9.Department of NeurosurgeryUniversity Hospital TübingenTübingenGermany
  10. 10.Department of Pediatric Oncology, Haematology and ImmunologyHeidelberg University HospitalHeidelbergGermany

Personalised recommendations